首页> 外文OA文献 >Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

【2h】

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

机译：Esimertinib患者高级表皮生长因子受体T790M突变阳性非小细胞肺癌：理由，证据和治疗中的基础

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Biagio Ricciuti; Sara Baglivo; Luca Paglialunga; Andrea De Giglio; Guido Bellezza; Rita Chiari; Lucio Crinò; Giulio Metro;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 第一代酪氨酸激酶抑制剂治疗中发生进展的非小细胞肺癌血浆表皮生长因子受体(EGFR) T790M突变提示了失败部位并预测了临床预后:一项前瞻性观察研究 [J] . Shirong Zhang, Lucheng Zhu, Bing Xia, 癌症（英文版） . 2018,第009期
2. Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy [J] . Biagio Ricciuti, Sara Baglivo, Luca Paglialunga, Therapeutic advances in medical oncology. . 2017,第6期

机译：Osimertinib在晚期表皮生长因子受体T790M突变阳性非小细胞肺癌患者中的作用：证据，证据和治疗方法
3. Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience [J] . Sullivan Ivana, Planchard David Therapeutic advances in respiratory disease. . 2016,第6期

机译：奥西替尼治疗表皮生长因子受体T790M突变阳性转移性非小细胞肺癌患者的临床试验证据和经验
4. Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience [J] . Ivana Sullivan, David Planchard Therapeutic advances in respiratory disease. . 2016,第6期

机译：Osimertinib治疗表皮生长因子受体T790M突变阳性转移性非小细胞癌的患者：临床试验证据和经验
5. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
6. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
7. Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale evidence and place in therapy [O] . Biagio Ricciuti, Sara Baglivo, Luca Paglialunga, 2017

机译：Osimertinib在晚期表皮生长因子受体T790M突变阳性非小细胞肺癌患者中的作用：证据证据和治疗方法
8. Rationale and design of a phase II trial of osimertinib as first-line treatment for elderly patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer (SPIRAL-0 study) [O] . Yusuke Chihara, Tadaaki Yamada, Junji Uchino, 2019

机译：ASIMERTINIB期作为老年表皮生长因子受体突变高级非小细胞肺癌的老年患者的一线治疗的基本原理与设计。（螺旋-0研究）

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

著录项

引文网络

相似文献

相关主题

期刊订阅